Advertisement

Topics

Latest "Calvert Laboratories" News Stories

01:43 EDT 21st July 2018 | BioPortfolio

Here are the most relevant search results for "Calvert Laboratories" found in our extensive news archives from over 250 global news sources.

More Information about Calvert Laboratories on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Calvert Laboratories for you to read. Along with our medical data and news we also list Calvert Laboratories Clinical Trials, which are updated daily. BioPortfolio also has a large database of Calvert Laboratories Companies for you to search.

Showing "Calvert Laboratories" News Articles 1–25 of 1,700+

Relevant

Concept Life Sciences adds to its scientific and commercial team

Dr Calvert and Dr Donaldson join the company to support growth


BioLargo Inc. CEO, Dennis Calvert, Returns to Uptick Newswire’s “Stock Day” Podcast for a ...

PHOENIX, Feb. 01, 2018 (GLOBE NEWSWIRE) Read more...

Reviewing IDEXX Laboratories (IDXX) & The Competition

IDEXX Laboratories is one of 25 publicly-traded companies in the "Diagnostic substances" industry, but how does it contrast to its rivals? We will compare IDEXX Laboratories to related businesses based on the strength of its dividends, analyst recommendations, institutional ownership, earnings, profitability, valuation and risk. IDEXX Laboratories has higher revenue and earnings than its rivals.


Reviewing Impax Laboratories

Impax Laboratories and Corcept Therapeutics are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations. 90.5% of Impax Laboratories shares are owned by institutional investors.

Critical Comparison: Impax Laboratories

Impax Laboratories and Innocoll are both small-cap pharmaceuticals - nec companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations. Innocoll has lower revenue, but higher earnings than Impax Laboratories.

Zacks: Brokerages Anticipate Impax Laboratories Inc (IPXL) Will Announce Earnings of $0.12 Per Share

Analysts forecast that Impax Laboratories Inc will post earnings per share of $0.12 for the current quarter, Zacks reports. Five analysts have made estimates for Impax Laboratories' earnings.

Brokers Issue Forecasts for Impax Laboratories Inc's Q1 2018 Earnings

Impax Laboratories Inc - Analysts at SunTrust Banks issued their Q1 2018 earnings estimates for Impax Laboratories in a report issued on Wednesday. SunTrust Banks analyst J. Boris expects that the specialty pharmaceutical company will earn $0.27 per share for the quarter.

Bionik Laboratories Issues Letter to Stockholders

I joined Bionik Laboratories as CEO in September 2017, having served as a director of the Company for the previous two months.  A focus Read more...

Deals this week: Dr. Reddy’s Laboratories, Pluristem Therapeutics, Fortress Biotech

Dr. Reddy’s Laboratories has signed a distribution agreement with UCB to supply the latter’s epilepsy drug Briviact in India. As...Read More... The post Deals this week: Dr. Reddy’s Laboratories, Pluristem Therapeutics, Fortress Biotech appeared first on Pharmaceutical Technology.

ACM acquires ABS to accelerate growth driven by clinical trials, toxicology

ACM Global Laboratories has acquired ABS Laboratories to better serve its clients in the clinical trial market with an expanded "scientific acumen," says company president.

Wickham Laboratories Holdings Announces Planning Application Approval

Published date:  22/01/2018 Summary:  Outline planning permission application for expansion of the Hoeford Point site now approved. Wickham Laboratories Holdings, owner of Wickham Laboratories Ltd, today announces approval of its application for planning permissi...

FDA Approves First Generic Version Of Suboxone

NewsDr. Reddy's Laboratories announces final approval and launch of Buprenorphine and Naloxone Sublingual Film in the U.S. market.

Riding bacterium to the bank

(DOE/Sandia National Laboratories) Jet fuel, pantyhose and plastic soda bottles: all three could be made from bioengineered bacteria, as Sandia National Laboratories has now demonstrated.

CloudLIMS? New Client Portal Enhances Customer Service Capabilities of Biobanks and Testing Laboratories

New portal is designed for biorepositories and testing laboratories

Diesel doesn't float this boat

(DOE/Sandia National Laboratories) Marine research could soon be possible without the risk of polluting either the air or the ocean. It's thanks to a new ship design and feasibility study led by Sandia National Laboratories.

Wickham Laboratories to exhibit at Making Pharmaceuticals UK 2018

Wickham Laboratories Ltd will exhibit on Stand 309 at the Making Pharmaceuticals Conference on 24 – 25 April 2018 at Ricoh Arena, Coventry... The post Wickham Laboratories to exhibit at Making Pharmaceuticals UK 2018 appeared first on

Tecan to Launch Fluent® Gx Automation Workstation for Use in Regulated Laboratories

The Fluent Gx is designed specifically to meet the needs of clinical and regulated laboratories

Dr. Reddy's Laboratories announces its intent to appeal court decision in preliminary ...

Dr. Reddy’s Laboratories Ltd.INVESTOR RELATIONSSAUNAK SAVLA, +91-40-49002135saunaks@drreddys.comorMEDIA RELATIONSCALVIN PRINTER, +91-40-49002121calvinprinter@drreddys.com Read more...

Zacks: Analysts Expect Impax Laboratories Inc (IPXL) Will Announce Quarterly Sales of $184.90 Million

Equities analysts expect Impax Laboratories Inc to announce sales of $184.90 million for the current fiscal quarter, according to Zacks . Four analysts have made estimates for Impax Laboratories' earnings.

IDEXX Laboratories Inc Reports Drop In Q4 Bottom Line

WASHINGTON (dpa-AFX) - IDEXX Laboratories Inc (IDXX) revealed earnings for fourth quarter that fell compared to the same period last year.The company said its earnings dropped to $38.26 million, o...

Wickham Laboratories to present at Cleanroom Technology Conference 2018

Wickham Laboratories CEO, Dr John McKenzie, will be presenting at the Cleanroom Technology Conference on the 16 May at 2:30PM, at the National Conference Centre in Birmingham... The post

Coming Soon to the Siemens Healthineers Aptio Automation System: iSpecimen Integrated Solution

"Soon-to-be discarded patient samples create an opportunity for laboratories to generate recurring revenue, while iSpecimen's network of laboratories helps researchers gain access to precisely the Read more...

Technical Perspectives on Drug Makers Stocks -- Impax Labs, Merck, Novartis, and Pfizer

Impax Laboratories Shares in Hayward, Californiaheadquartered Impax Laboratories Inc. rose slightly by 0.78%, ending Wednesday's trading session at $19.45. The stock recorded a Read more...

Ipca Laboratories' net jumps by 15.9% to Rs. 51 crore in Q4

Ipca Laboratories has posted net profit growth of 15.9 per cent during the fourth quarter ended March 2018 to Rs. 51 crore from Rs. 44 crore in the similar period of last year.

Merck to distribute HistoCyte Laboratories’ cell line products

Pharmaceutical company Merck has signed an agreement to become the exclusive multinational distributor of HistoCyte Laboratories’ portfolio of cell line...Read More... The post Merck to distribute HistoCyte Laboratories’ cell line products appeared first on Pharmaceutical Technology.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks